MELISSA SMITH: Open Payments
NPI 1043759681 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 31 payments from 16 companies in 2025. Trend: 2023 $1,746 · 2024 $2,733 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 3 | $214 |
| Merck Sharp & Dohme LLC | 4 | $107 |
| Amgen Inc. | 5 | $75 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Boston Scientific Corporation | 2 | $47 |
| Actelion Pharmaceuticals US, Inc. | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Kestra Medical Technology Services, Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
Products named: VERQUVO, REPATHA, LifeVest, EMBLEM MRI S-ICD, FARXIGA, CAPVAXIVE, Kerendia, LOKELMA.
Industry payments across TX — which companies pay providers there.
